The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Type Ii Anti-Cd20 Antibody For Reducing Formation Of Anti-Drug Antibodies - EP3387015

The patent EP3387015 was granted to F Hoffmann LA Roche on Oct 27, 2021. The application was originally filed on Dec 6, 2016 under application number EP16810283A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3387015

F HOFFMANN LA ROCHE
Application Number
EP16810283A
Filing Date
Dec 6, 2016
Status
Granted And Under Opposition
Sep 24, 2021
Publication Date
Oct 27, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANJul 26, 2022GREAVES BREWSTERADMISSIBLE

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTWO2009134738
INTERNATIONAL-SEARCH-REPORTWO2012107417
INTERNATIONAL-SEARCH-REPORTWO2012117002
INTERNATIONAL-SEARCH-REPORTWO2014056783
INTERNATIONAL-SEARCH-REPORTWO2015095410
OPPOSITIONUS2010003252

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents